NovaDel Pharma Inc. Company Profile

01:03 EDT 24th May 2015 | BioPortfolio

NovaDel Pharma Inc. is a specialty pharmaceutical company developing oral spray formulations for a broad range of marketed drugs. The Company’s proprietary technology offers, in comparison to conventional oral dosage forms, the potential for faster absorption of drugs into the bloodstream leading to quicker onset of therapeutic effects and possibly reduced first pass liver metabolism, which may result in lower doses. Oral sprays eliminate the requirement for water or the need to swallow, potentially improving patient convenience and adherence.


News Articles [894 Associated News Articles listed on BioPortfolio]

NovaDel Pharma sells remaining assets of ZolpiMist NDA to Amherst for $2.2m

As previously reported, NovaDel Pharma has sold its remaining assets, which consisted of the ZolpiMist NDA, a license agreement and related global intellectual property to Amherst Pharmaceuticals in e...

NovaDel Announces Update to Agreement with Amherst Pharmaceuticals

As previously reported, NovaDel Pharma, Inc. (NVDL.PK) has sold its remaining assets, which consisted of the ZolpiMist® NDA, a license agreement and related global intellectual p...

VERONA PHARMA PLC - CMO appointment & incorporation of Verona Pharma Inc

Verona Pharma plc ("Verona Pharma" or the "Company") Appointment of Dr Kenneth Newman as Chief Medical Officer and Incorporation of Verona Pharma, Inc. 17 December 2014, Cardiff - Verona Pharma pl...

Endo’s Purchase of Par Pharma Shakes up the Industry

US Pharma M&A activity has yet to show any signs of a slowdown after the $8.1bn exit of Par Pharma by TPG to Endo was announced on Monday. The US Pharma industry has seen 39 deals valued at US$ 77...

Celtic Pharma: Attracting Big Pharma with experience and raising US$ 750M

In this interview, filmed at PharmaTelevision’s Oxford Studios, Dr Fintan Walton speaks with Stephen Parker, Partner at Celtic Pharma, a source of private equity and venture capital created in 2004....

Cocrystal Pharma and RFS Pharma Merge to Create Antiviral Development Organization

Cocrystal Pharma, a biotechnology company developing novel antiviral therapeutics for human diseases, today announced the closing of its merger with RFS Pharma, LLC, a privately owned biotech company ...

Cocrystal Pharma and RFS Pharma complete merger

USA-based biotech firm Cocrystal Pharma has announced the closing of its merger with RFS Pharma, a privately owned biotech company founded by renowned drug developer, Raymond Schinazi.

Kaldi Pharma partners A2a/A1 antagonist with CleveXel Pharma

Kaldi Pharma, a special-purpose financing vehicle concurrently created by Domain Therapeutics SA, licensed CleveXel Pharma worldwide rights to the preclinical A2a/A1 antagonist CVXL0069 (formerly DT09...

Drugs and Medications [238 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

PubMed Articles [21 Associated PubMed Articles listed on BioPortfolio]

Discovery of a novel trimebutine metabolite and its impact on N-desmethyltrimebutine quantification by LC-MS/MS.

Hélène Montpetit has a Bachelor of Science in Biochemistry from the University du Québec at Montreal. For the past 15 years, she has worked in the bioanalysis field in CROs environment as well as i...

The premium of a big pharma license deal.

Pharma partners with efforts to pool patient genotype and phenotype data.

Pharmaceutical industry, academia and patient advocacy organizations: What is the recipe for synergic (win-win-win) collaborations?

Biological complexity and the need for highly differentiated medicines means that drug discovery and development have become increasingly challenging and expensive. Thus, new paradigms for research an...

Best of Both Worlds: Combining Pharma Data and State of the Art Modeling Technology To Improve in Silico pKa Prediction.

In a unique collaboration between a software company and a pharmaceutical company, we were able to develop a new in silico pKa prediction tool with outstanding prediction quality. An existing pKa pred...

Clinical Trials [45 Associated Clinical Trials listed on BioPortfolio]

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions

To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.

Safety and Efficacy of LCP-Tacro™ Once Daily in Stable Renal Transplant Patients Converted From Prograf® Twice Daily

This is 2-armed parallel group, prospective, randomized, open-label, multicenter Phase 3 controlled trial to establish the efficacy and safety of conversion from maintenance immunosuppress...

Development of a New Method for Analgesia

Aim: To examine a new method to perform local anesthesia in order to diminish the inconvenience by the procedure in patients before performing intubation or oesophagogastroduodenoscopy.

Companies [661 Associated Companies listed on BioPortfolio]

Novadel Pharma, Inc.

NovaDel Pharma Inc. is a specialty pharmaceutical company that previously developed oral spray formulations of marketed pharmaceutical products. The Company has discontinued its o...

NovaDel Pharma

NovaDel Pharma Inc. is a specialty pharmaceutical company developing oral spray formulations of a broad range of marketed treatments for serious diseases. The Company’s proprietary technology enabl...

NovaDel Pharma Inc.

NovaDel Pharma Inc. is a specialty pharmaceutical company developing oral spray formulations for a broad range of marketed drugs. The Company’s proprietary technology offers,...

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and ...

LEO Pharma Inc.

LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...

More Information about "NovaDel Pharma Inc." on BioPortfolio

We have published hundreds of NovaDel Pharma Inc. news stories on BioPortfolio along with dozens of NovaDel Pharma Inc. Clinical Trials and PubMed Articles about NovaDel Pharma Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NovaDel Pharma Inc. Companies in our database. You can also find out about relevant NovaDel Pharma Inc. Drugs and Medications on this site too.

Search BioPortfolio:
Loading
Advertisement
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record